Varian Medical Systems (VAR) Tops Q3 EPS by 2c; Guides FY Mildly Below the Street

Varian Medical Systems (NYSE: VAR) reported Q3 EPS of $1.13, $0.02 better than the analyst estimate of $1.11. Revenue for the quarter came in at $784 million versus the consensus estimate of $810.41 million.

Varian Medical Systems sees FY2015 EPS of $4.20-$4.25, versus the consensus of $4.29.

"The third quarter was mixed for Varian with double-digit constant currency gross orders growth in Oncology Systems, significant challenges in Imaging Components, and strong performance in Particle Therapy," said Dow R. Wilson, CEO of Varian Medical Systems. "The stronger U.S. dollar continued to have a big impact on our performance, contributing to lower margins. Excellent cost controls enabled us to deliver solid earnings for the period."

For earnings history and earnings-related data on Varian Medical Systems (VAR) click here.

You May Also Be Interested In

• Integra LifeSciences cuts 2026 outlook after Cincinnati flood
• Rivian reports record Q3 deliveries, beats estimates, shares rise
• ConAgra Brands (CAG) Tops Q1 EPS by 13c, Beats on Revenue; Offers FY27 EPS Guidance